feed,title,long_url,short_url
Benzinga,FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder,https://benzinga.com/general/biotech/23/03/31470034/fda-adcomm-says-benefit-risk-profile-favor-biogens-tofersen-for-inherited-neuro-disorder,https://da.gd/OljO
